FDA NDC Directory · JSON-LD · Markdown

Rufinamide

NDC 67877-673 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Labeler / ManufacturerAscend Laboratories, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA213410
Dosage form / routeSUSPENSION · ORAL
Active ingredientsRUFINAMIDE (40 mg/mL)
Marketing started20210224
Package count1

External sources

Source: openFDA. Public-domain (CC0).